Description: This session from the 2003 SOA Orlando Meeting presents various predictive models, evaluation methodologies, control groups, current and potential uses for predictive modeling and issues surrounding implementation of a predictive modeling process. From the Record of the Society of Actuaries, Volume 29, No. 3.

Description: Panelists discuss opportunities to improve medical cost trends through underwriting, healthcare benefit designs, contracting, network management, claims operations, and medical management. From the Record of the Society of Actuaries, Vol. 31, No. 2, Session 40

Description: This session describes the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. We will walk through the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. We will also walk through some sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: SOA’s recently completed research project related to long term projects of health care cost trends for use in post retirement medical valuations.

Description: The Effect of Medical Technology on Health Care Cost, the Effect of Health Care on Longevity and Vice Versa.

Description: The article describes the insurance industry's preparation for pandemic events and the public finance response.

Description: Projecting start-up capital requirements for Health care co-ops and public plans

Description: Because of increasing longevity in the world's population, a larger proportion of people will live long enough to develop chronic diseases. Because of their large numbers and extent of their individual expenses, the public sector will need to intervene to help these patients and their families. From Financing Chronic Care Monograph, M-HB05-1.

Description: This paper offers basic, economic and actuarial ideas to improve the balance of cost, access to treatment and quality over time.